Tag: tissue microarray industry players

  • 2024 Tissue Microarray Market Analysis: Market Size, Key Drivers, and Segment Insights

    2024 Tissue Microarray Market Analysis: Market Size, Key Drivers, and Segment Insights

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What Will Be the Growth Trajectory of the Tissue Microarray Market from 2024 to 2033?

    The tissue microarray industry has witnessed substantial expansion in the recent past. The growth rate is forecasted to rise from $11.17 billion in 2023 to $12.36 billion in 2024, showing a compound annual growth rate (CAGR) of 10.7%. The previous period’s surge in the market is linked to the emergence of precision medicine, advancements in drug discovery and development, effective analysis, increasing incidences of chronic ailments, and initiatives in biobanking.

    The market size of tissue microarray is projected to experience a significant surge in the next couple of years, expanding to a whopping $18.68 billion by 2028 with a compound annual growth rate (CAGR) of 10.9%. The predicted expansion in the forthcoming timeframe is mostly owing to factors like the rise of digital pathology, wider application spectrum, ascending biopharmaceutical industry, supportive regulatory norms and standards, and incorporation of AI and machine learning. Going forward, the key trends projected to reshape the forecast period encompass improvements in imaging technologies, progression in 3D tissue microarrays, advanced high-content screening, standardization efforts, and integration of single-cell analysis.

    Claim Your Free Sample of the Global Tissue Microarray Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12236&type=smp

    What Are the Primary Growth Drivers for the tissue microarray Market?

    Rise in cancer incidents is predicted to boost the growth of the tissue microarray market in the future. Cancer refers to a variety of diseases that originate in any organ or tissue when rogue cells start to multiply uncontrollably, exceeding their natural boundaries, and either invade adjacent body parts or metastasize to other organs. In the field of oncology, tissue microarrays are employed to study the expression of biomarkers related to cancer in a range of tumor samples. For example, the American Cancer Society Inc., a non-profit organization in the US, anticipates 609,820 cancer fatalities and 1,958,310 fresh cancer diagnoses in the country during 2022, as of January 2023. As a result, the escalating number of cancer situations is fuelling the expansion of the tissue microarray market.

    What Are the Defining Segments of the Tissue Microarray Market?

    1) By Type: Immunohistochemistry, Fluorescent In Situ Hybridization, Frozen Tissue Array, Other Types

    2) By Technology: Deoxyribonucleic Acid (DNA) Microarray, Polymerase Chain Reaction (PCR), Next-Generation Sequencing, Northern Blotting, Western Blotting

    3) By Application: Oncology, Gene Expression Profiling, Single Nucleotide Polymorphism (SNP) Detection, Double-Stranded B-DNA Microarrays, Comparative Genomic Hybridization, Sequencing Bioinformatics

    4) By End-User: Pharmaceutical And Biotechnological Companies, Research Organization, Hospitals

    What Trends Are Revolutionizing Standards in the Tissue Microarray Market?

    The emergence of strategic collaborations is a significant trend within the tissue microarray market. Top-tier firms active in this sector are initiating collaborations for the establishment of new alliances aimed at developing tissue microarray technologies. For example, in November 2022, The Cureline Group, an American CRO specializing in translational and precision medicine through its HBS biobanking and lab services, joined forces with Cellecta Inc., a firm offering RNAi and CRISPR screening products and services based in the US. Their combined initiative, the Tissue 2 Target Services, intends to mesh their key proficiencies in cellular and tissue molecular analysis and human biospecimen handling to supply pre-clinical and translational research utilities. These utilities focus on the discovery of gene targets and biomarker services for efficient workflow routines. Meanwhile, in September 2022, Ultivue Inc., an American bio-tech company creating solutions for maximizing accessible biological data from cellular and tissue samples, established a partnership with ngTMA, a Swiss TRU platform under Bern University that innovates workflows for creating tissue microarray. This collaboration aims to boost the development of multiplex immunofluorescence (mIF) assays and introduce new TMA technologies, ultimately unlocking in-depth spatial analysis in scientific studies and improving the quality of TMAs applied in clinical and translational research.

    Order Now for Fast Delivery of Your Tissue Microarray Market Report!

    https://www.thebusinessresearchcompany.com/report/tissue-microarray-global-market-report

    What Regions Are Propelling Growth in the Tissue Microarray Industry?

    North America was the largest region in the tissue microarray market in 2023. Asia-Pacific is expected to be the fastest-growing region in the tissue microarray market report during the forecast period. The regions covered in the tissue microarray market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    The Tissue Microarray Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the tissue microarray market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Tissue Microarray Market Include

    1. Tissue Microarray Market Executive Summary

    2. Tissue Microarray Market Segments

    3. Tissue Microarray Market Size And Template Market Growth Rate

    4. Key Tissue Microarray Market Trends

    5. Major Tissue Microarray Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Tissue Microarray Market

    26. Top Tissue Microarray Companies

    27. Tissue Microarray Market Opportunities And Strategies

    28. Tissue Microarray Market, Conclusions And Recommendations

    29. Appendix

    Discover Related Reports by The Business Research Company:

    Tissue Engineering Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/tissue-engineering-global-market-report

    Facial Tissues Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/facial-tissues-global-market-report

    Cardiovascular And Soft Tissue Repair Patches Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/cardiovascular-and-soft-tissue-repair-patches-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Future Growth Forecast For The Tissue Microarray Global Market 2024-2033

    Future Growth Forecast For The Tissue Microarray Global Market 2024-2033

    The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

     The tissue microarray market has been experiencing rapid expansion, propelled by various factors. Here’s a closer look at its growth trajectory:

    • Historical Growth: From $11.17 billion in 2023 to $12.36 billion in 2024, boasting a CAGR of 10.7%. This growth is attributed to the rise of precision medicine, drug discovery, efficient analysis, and the prevalence of chronic diseases.
    • Forecasted Surge: Anticipated growth to $18.68 billion in 2028, with a CAGR of 10.9%. Key drivers include digital pathology, expanded applications, the biopharmaceutical industry’s growth, regulatory support, and AI integration.

    Driving Forces Behind Market Expansion

    1. Surging Cancer Cases
    • The increasing incidence of cancer acts as a significant growth catalyst.
    • Tissue arrays play a vital role in oncology, aiding in the examination of cancer-related biomarkers in tumor samples.
    • In 2022, it is estimated that the US will see 1,958,310 new cancer cases and 609,820 cancer-related deaths.

    View More On The Tissue Microarray Market Report 2024 – https://www.thebusinessresearchcompany.com/report/tissue-microarray-global-market-report

    1. Strategic Partnerships
    • Collaborations drive innovation in the tissue microarray market.
    • Partnerships like that between The Cureline Group and Cellecta Inc. aim to enhance molecular analysis and biospecimen management, offering streamlined research services.
    • Ultivue Inc. partnering with ngTMA focuses on advancing multiplexed immunofluorescence assays and applying new TMA technologies for spatial analysis.
    1. Acquisitions
    • Strategic acquisitions bolster companies’ capabilities and geographic reach.
    • BioIVT’s acquisition of Tissue Solutions Ltd expands access to high-quality biospecimens and broadens its collection network with 150 additional sites.

    Market Segmentation and Regional Outlook

    The tissue microarray market is segmented based on type, technology, application, and end-user:

    1. Type: Immunohistochemistry, Fluorescent In Situ Hybridization, Frozen Tissue Array, Other Types
    2. Technology: DNA Microarray, PCR, Next-Generation Sequencing, Northern Blotting, Western Blotting
    3. Application: Oncology, Gene Expression Profiling, SNP Detection, Comparative Genomic Hybridization, Sequencing Bioinformatics
    4. End-User: Pharmaceutical And Biotechnological Companies, Research Organizations, Hospitals
    • Regional Dynamics: North America dominated the market in 2023, while the Asia-Pacific region is expected to witness the fastest growth.

    Conclusion: Embracing the Future

    The tissue microarray market is poised for significant expansion, driven by technological advancements, strategic alliances, and increasing healthcare demands. With cancer cases on the rise and a growing emphasis on precision medicine, the demand for tissue arrays is set to soar. As the market evolves, stakeholders must leverage innovation and collaboration to address emerging challenges and capitalize on opportunities. By staying at the forefront of advancements, the tissue microarray market can continue to revolutionize diagnostics and therapeutics, ultimately enhancing patient outcomes worldwide.

    Request A Sample Of The Global Tissue Microarray Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=12236&type=smp